Roche Media 3. März 2026 Roche: Sustainable Operations, Supply Chains & AI in Health - Sustainability Magazine
Roche Media 2. März 2026 Roche reports pivotal MS win, but deaths add to safety questions - Fierce Biotech
Roche Media 24. Feb. 2026 Roche halts development of satralizumab for DMD bone health - Muscular Dystrophy News
Roche Media 23. Feb. 2026 Roche halts development of Enspryng in Duchenne muscular dystrophy - Fierce Pharma
Roche Media 20. Feb. 2026 Roche taps Aussie oncologist to lead research—Chutes & Ladders - Fierce Biotech
Roche Media 19. Feb. 2026 Roche to end manufacturing of key antibiotic amid EU’s generic woes - Euractiv
Roche Media 18. Feb. 2026 Paragon's latest biotech will try to slow Alzheimer's like Roche - Endpoints News
Roche Media 9. Feb. 2026 Roche’s fenebrutinib demonstrates decade-first benefit in multiple sclerosis - European Pharmaceutical Review
Roche Media 9. Feb. 2026 Roche unveils data behind BTK inhibitor's phase 3 multiple sclerosis win in Ocrevus trial - Fierce Biotech
Roche Media 6. Feb. 2026 Genentech cut at least 489 jobs last year, new filing reveals - Fierce Biotech
Roche Media 2. Feb. 2026 Roche continues RNA return with $1.7B deal for Sanegene drug - Fierce Biotech
Roche Media 29. Jan. 2026 Roche Expands Clinical Research in Mexico, Invests MX$1.2 Billion - Mexico Business News
Roche Media 29. Jan. 2026 Roche’s 2025 profit blunted by weakened US dollar - Pharmaceutical Technology